REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/11/2025
Back to search
Official data from USPTO
HCCBLOODTEST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HCCBLOODTEST
ST13
US500000088311970Class
1, 5, 9
Filing
88311970
Registration
6126563
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
61
Latest update
08/12/2025
Trademark type
Word
Nice classes
1, 5, 9
Filing date
02/22/2019
Registration date
08/11/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/11/2020
Last transaction
08/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Foreign priority
First use anywhere
2018-08-00
First use in commerce
2019-02-00
Drawing code
4
Owner type
99
Owner location
Berlin, DE
Examiner
CORDOVA, RAUL
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Epigenomics AG
Representatives
Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and sciencereagents used in sciencefor forensic examinations and test kits used in sciencein particular for verifyingdiagnosingmonitoring and predicting the progresstreatment outcome and post treatment of illnessessuch as inflammatoryinfectiouscentral nervous systemcardiovascularneurologicalendocrineautoimmune and genetic diseases and cancer
Class 5
Pharmaceutical productsreagents for medical usefor verifyingdiagnosingmonitoring and predicting the progresstreatment outcome and post-treatment of inflammatoryinfectiouscentral nervous systemcardiovascularneurologicalendocrineautoimmune and genetic diseases and cancerin particular comprising of reagentschemical preparations for the diagnosis of inflammatoryinfectiouscentral nervous systemcardiovascularneurologicalendocrineautoimmune and genetic diseases and cancerassaysdiagnostic test slidesdiagnostic test patchessold as a unit
Class 9
Scientific instrumentsanalyzers for biological substances and samples; laboratory apparatusin particular apparatus for screening biological samplesfor detecting the presence of substances in samples and for identifying sample types; all for research use or scientific use
Publications
History of USPTO decisions and trademark events.
61 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/23/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/23/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/23/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/23/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/23/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/16/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/16/2021
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
08/11/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/07/2020
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
07/01/2020
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
06/30/2020
IUAA
USE AMENDMENT ACCEPTED
06/30/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/23/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/23/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/23/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/23/2020
GNFR
FINAL REFUSAL E-MAILED
06/23/2020
CNFR
FINAL REFUSAL WRITTEN
06/23/2020
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/30/2020
IUAF
USE AMENDMENT FILED
05/30/2020
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/29/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/07/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/05/2020
GNSL
LETTER OF SUSPENSION E-MAILED
05/05/2020
CNSL
SUSPENSION LETTER WRITTEN
05/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/14/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/14/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/27/2020
GNRT
NON-FINAL ACTION E-MAILED
03/27/2020
CNRT
NON-FINAL ACTION WRITTEN
03/27/2020
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
03/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/28/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/27/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/03/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/03/2020
CNSI
SUSPENSION INQUIRY WRITTEN
01/03/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/19/2019
ALIE
ASSIGNED TO LIE
12/13/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/05/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/06/2019
GNSL
LETTER OF SUSPENSION E-MAILED
06/06/2019
CNSL
SUSPENSION LETTER WRITTEN
06/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/14/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/10/2019
GNRT
NON-FINAL ACTION E-MAILED
05/10/2019
CNRT
NON-FINAL ACTION WRITTEN
05/10/2019
DOCK
ASSIGNED TO EXAMINER
05/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/14/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
03/02/2019
ALIE
ASSIGNED TO LIE
02/28/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/26/2019
NWAP
NEW APPLICATION ENTERED
02/26/2019
Continuous trademark protection
Get notified about every new filing that threatens HCCBLOODTEST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.